首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1529590

體內 CRO 市場：依分子類型、依治療領域、按服務類型、按地區

In Vivo CRO Market, By Type of Molecule, By Therapeutic Area, By Service Type, By Geography

出版日期: 2024年07月10日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球體內CRO市場規模為47億美元，預計2031年將達83.1億美元，2024年至2031年複合年成長率為8.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	47億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期複合年成長率	8.50%	2031 年金額預測	83.1億美元

圖：2024 年體內 CRO市場佔有率（按地區）

體內 CRO 市場包括受託研究機構(CRO)，這些組織在藥物開發的非臨床或臨床前階段協助製藥和生技公司，並將其研究需求外包給這些專業公司。 CRO 使用活體動物進行實驗和測試，以幫助評估候選藥物的功效、毒性和安全性。這降低了藥物開發商的風險並加快了醫藥品認證過程。增加藥品和醫療創新的研發支出是全球體內 CRO 市場成長的關鍵驅動力。然而，嚴格的動物福利法規和對替代檢測方法的需求不斷增加等因素給市場帶來了挑戰。

市場動態

全球體內 CRO 市場受到醫藥品研究開發費用增加、疾病治療進步以及減少藥物開發時間和成本日益成長的需求的推動。然而，對動物測試的嚴格規定以及對晶片器官和體外測試等替代測試方法的日益偏好正在限制市場。人類晶片技術的開拓為進入該市場的公司提供了一個機會，可以提供新穎的替代測試解決方案，並與行業向非動物測試方法的轉變保持一致。 COVID-19 的爆發凸顯了 CRO 發現治療方法並協助藥廠進行臨床前研究的必要性。

本研究的主要特點

- 本報告詳細分析了全球體內 CRO 市場，包括以 2023 年為基準年的預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球體內 CRO 市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
In Vivo CRO 全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於全球體內 CRO 市場分析的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- IQVIA Inc.
- Crown Bioscience
- Taconic Biosciences, Inc.
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research（I）Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health

第10章分析師建議

上升和下降
綜合機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI7148

The global in vivo CRO market is estimated to be valued at USD 4.70 Bn in 2024 and is expected to reach USD 8.31 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 4.70 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.50%	2031 Value Projection:	US$ 8.31 Bn

Figure. In Vivo CRO Market Share (%), By Region 2024

In vivo CRO market involves contract research organizations (CROs) that help pharmaceutical and biotechnology companies in non-clinical or pre-clinical stages of drug development by outsourcing their research needs to these specialized firms. CROs conduct experiments and tests on live animals and help evaluate the efficacy, toxicity, and safety of new drug candidates. This reduces risks for drug developers and accelerates the drug approval process. Rising R&D expenditure on pharmaceuticals and medical innovations is a key driver for growth of the global in vivo CRO market. However, factors such as stringent animal welfare regulations and increasing demand for alternative testing methods pose challenges for the market.

Market Dynamics

The global in vivo CRO market is driven by rising pharmaceutical R&D expenditure, advancements in disease treatment, and growing need to reduce drug development timelines and costs. However, stringent regulations for animal testing and rising preference for alternative testing methods, such as organ-on-chip and in vitro testing, act as restraints for the market. Development of human-on-chip technology provides an opportunity for companies in this market to offer novel alternative testing solutions and align with industry shift toward non-animal methods. The COVID-19 outbreak highlighted the need for CROs to find treatments and help drug makers in pre-clinical research, thereby presenting lucrative prospects for players in this market.

Key Features of the Study:

-This report provides in-depth analysis of the global in vivo CRO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in vivo CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Charles River, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Changle Rongshi, Pengxin Huasu and Syngene International.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global in vivo CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vivo CRO market.

Detailed Segmentation-

By Type of Molecule
- Small Molecules
- Large Molecules
By Therapeutic Area
- Oncology
- Cardiology
- Diabetes
- Autoimmune/Inflammation Conditions
- Infectious Diseases
- CNS Conditions
- Others
By Service Type
- Preclinical Testing
- Clinical Research Services
- Laboratory Services
- Consulting Services
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- IQVIA Inc.
- Crown Bioscience
- Taconic Biosciences, Inc.
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research (I) Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type of Molecule
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Service Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global In Vivo CRO Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global In Vivo CRO Market, By Type of Molecule, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global In Vivo CRO Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune/Inflammation Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CNS Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global In Vivo CRO Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Preclinical Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Research Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Laboratory Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consulting Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global In Vivo CRO Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Molecule, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- IQVIA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Crown Bioscience
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Taconic Biosciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PsychoGenics Inc.
- Evotec
- Janvier Labs
- Biocytogen Boston Corp
- GemPharmatech
- Charles River Laboratories
- Icon Plc
- Labcorp Drug Development
- Parexel International Corporation
- SMO Clinical Research (I) Pvt Ltd.
- WuXi AppTec
- ICON plc
- Syneos Health